Why Is COVISTA INC (CVSA) Stock Up Today?

CVSA stock rose 12.57% to $139.88 on Tuesday, driven by the company’s strong Q4 FY2026 results and the initiation of FY2027 guidance. Covista reported adjusted earnings per share of $2.09, exceeding the $1.89 estimate, and raised its full-year adjusted EPS and revenue forecasts. The company also announced $238 million in share repurchases and outlined plans for campus expansion and AI initiatives.

What Happened

Covista released its Q4 FY2026 earnings report on August 6, 2026, showing revenue of $501.4 million, a 9.7% increase year-over-year, and adjusted EBITDA of $126.9 million. The company exceeded both top- and bottom-line expectations and raised its full-year guidance. For FY2027, Covista projected revenue of $2.05 billion to $2.09 billion and adjusted EPS of $8.90 to $9.15, both above the consensus estimates. The company also detailed new partnerships, including a collaboration with Chamberlain University and Advocate Health to expand nursing education and employment pathways. These developments were accompanied by a slide deck and an 8-K filing with the SEC.

What The Data Shows

The stock opened at $127.19, up 2.4% from the prior close, and climbed to a session high of $140.65 before settling at $139.88. The session saw 0.1 million shares traded, which is 0.4 times the 3-month average. Covista’s fundamentals include a market cap of $4.4 billion, a P/E ratio of 18.1, and a 12.3% net margin. The stock has traded between $86.97 and $156.26 over the past 52 weeks. Recent insider transactions include eight sales totaling $7.6 million in the last 90 days, with no buys reported. Donald J. Trump disclosed a purchase of $15,001 to $50,000 in February.

What To Watch

Covista has no scheduled earnings date in the immediate future. Investors should monitor the company’s coverage breadth and the reaction to its FY2027 guidance as it unfolds in the coming quarters.